These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 710423)

  • 1. The binding of low-affinity and high-affinity heparin to antithrombin. Competition for the same binding site on the protein.
    Danielsson A; Björk I
    Eur J Biochem; 1978 Sep; 90(1):7-12. PubMed ID: 710423
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies.
    Nordenman B; Danielsson A; Björk I
    Eur J Biochem; 1978 Sep; 90(1):1-6. PubMed ID: 710412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence by chemical modification for the involvement of one or more tryptophanyl residues of bovine antithrombin in the binding of high-affinity heparin.
    Björk I; Nordling K
    Eur J Biochem; 1979 Dec; 102(2):497-502. PubMed ID: 527591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies.
    Nordenman B; Björk I
    Biochemistry; 1978 Aug; 17(16):3339-44. PubMed ID: 687588
    [No Abstract]   [Full Text] [Related]  

  • 5. The binding of 1-anilino-8-naphthalenesulfonate, heparin, salicylate and caprylate by human antithrombin III.
    Einarsson R
    Biochim Biophys Acta; 1976 Sep; 446(1):124-33. PubMed ID: 974107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant activity of heparin: isolation of antithrombin-binding sites.
    Hopwood J; Höök M; Linker A; Lindahl U
    FEBS Lett; 1976 Oct; 69(1):51-4. PubMed ID: 992045
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.
    Horner AA; Kusche M; Lindahl U; Peterson CB
    Biochem J; 1988 Apr; 251(1):141-5. PubMed ID: 3390150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139.
    Arocas V; Turk B; Bock SC; Olson ST; Björk I
    Biochemistry; 2000 Jul; 39(29):8512-8. PubMed ID: 10913257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prothrombinase at macroscopic lipid membranes: competition between antithrombin and prothrombin.
    Billy D; Speijer H; Lindhout T; Hemker HC; Willems GM
    Biochemistry; 1995 Oct; 34(41):13699-704. PubMed ID: 7577961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
    Yuan QP; Walke EN; Sheehan JP
    Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding to antithrombin of heparin fractions with different molecular weights.
    Danielsson A; Björk I
    Biochem J; 1981 Feb; 193(2):427-33. PubMed ID: 7305940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.
    Horner AA
    Biochem J; 1989 Sep; 262(3):953-8. PubMed ID: 2590178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
    Futamura A; Beechem JM; Gettins PG
    Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of conformational change from the heparin binding site to the reactive center of antithrombin.
    Gettins PG; Fan B; Crews BC; Turko IV; Olson ST; Streusand VJ
    Biochemistry; 1993 Aug; 32(33):8385-9. PubMed ID: 8357789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.